Accelerate biotechnology

Batavia Biosciences Receives Grant from the Bill & Melinda Gates Foundation to Support Vaccine Availability in Developing Countries

Advanced cell-line technology could reduce costs of vaccine production Leiden, The Netherlands, and Woburn, MA, 9th June 2016 Batavia Biosciences is committed to increase vaccine availability and affordability for the developing world and has received a $3.8 million grant from the Bill & Melinda Gates Foundation to fund this work. Despite many advances in manufacturing technologies…


Batavia Biosciences is a finalist and Ruban d’Honneur recipient in the 2015/16 European Business Awards competition

Batavia Biosciences was selected as finalist by an esteemed panel of judges made up of European leading business & political leaders, academics & entrepreneurs. Starting with more than 32,000 companies from 33 countries across Europe, Batavia Biosciences made it to Europe’s 110 most dynamic and exciting businesses. According to the jury, Batavia Biosciences actively demonstrates the…


Menzo Havenga has been awarded the prestigious title “CEO of the year” by Acquisition International for outstanding business achievements

The award is based on the rapid and sustainable growth of Batavia Biosciences in the first five years after incorporation exceeding all industry standards and growing 58% average annual growth rate (CAGR) to a current turnover of 12 million Euro, more than 80 FTE, and laboratory infrastructure in Netherlands (Leiden) and USA (Boston). Acquisition International…


Batavia Biosciences GEWELDIG in innovatie, STERK in groei

Batavia Biosciences is in vijf jaar tijd gegroeid van een kleine start-up naar een bedrijf met meer dan 80 medewerkers en een solide laboratorium infrastructuur in zowel Nederland (Leiden) als Amerika (Boston). De omzet van dit bedrijf groeide in deze periode met meer dan een factor 10. De snelle groei wordt gerealiseerd doordat Batavia Biosciences…


Batavia Biosciences Netherlands moves to new facility

To accommodate the fast growth of our company, Batavia Biosciences needed a new facility in the Netherlands. Therefore a brand new, state of the art, office and laboratory infrastructure was built just across the street of the current location at the Leiden Bioscience Park. We are proud to announce that as of December 14 our new…


Batavia Biosciences represent the Netherlands in prestigious European Business competition.

Leiden, the Netherlands, September 17, 2015 Batavia Biosciences is proud to represent the Netherlands as a National Champion in the prestigious international competition for the European Business Awards 2015/2016. As a biopharmaceutical product developer Batavia Biosciences has been recognized to stand out with its unique innovative technologies and major contributions on the control and prevention…


Wouter van Catz joined the management team as Manager Finance

Batavia Biosciences B.V., announced the appointment of Wouter van Catz as Manager Finance per May 2015. Wouter van Catz, brings to Batavia Biosciences more than 10 years of experience in business controlling and auditing. Prior to joining Batavia Biosciences Wouter assumed positions at Octoplus BV, the Netherlands (Financial Controller) and Biomet BV The Netherlands (Corporate…


Press release: A new name, in keeping with a recognised market position

Batavia Biosciences Leiden, the Netherlands, April 24 2015 Batavia Bioservices announces its decision to change its name to Batavia Biosciences as of April 23, 2015. The change will coincide with the launch of a new website and multimedia communication strategy. Since its establishment in 2009, the company has experienced rapid growth and has established itself…